GB1208014A - Cephalosporins - Google Patents
CephalosporinsInfo
- Publication number
- GB1208014A GB1208014A GB03867/67A GB1386767A GB1208014A GB 1208014 A GB1208014 A GB 1208014A GB 03867/67 A GB03867/67 A GB 03867/67A GB 1386767 A GB1386767 A GB 1386767A GB 1208014 A GB1208014 A GB 1208014A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- chloro
- chloride
- prepared
- cephalosporanic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229930186147 Cephalosporin Natural products 0.000 title abstract 3
- 229940124587 cephalosporin Drugs 0.000 title abstract 3
- 150000001780 cephalosporins Chemical class 0.000 title abstract 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 abstract 3
- 229920005989 resin Polymers 0.000 abstract 3
- 239000011347 resin Substances 0.000 abstract 3
- IWLHOUBDKCKJJQ-UHFFFAOYSA-N 1-(3-iodophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(I)=C1 IWLHOUBDKCKJJQ-UHFFFAOYSA-N 0.000 abstract 2
- ARKIFHPFTHVKDT-UHFFFAOYSA-N 1-(3-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC=CC([N+]([O-])=O)=C1 ARKIFHPFTHVKDT-UHFFFAOYSA-N 0.000 abstract 2
- RYMLPVGCISRSRQ-UHFFFAOYSA-N 2-(4-chloro-3-nitrophenyl)-2-hydroxyacetic acid Chemical compound OC(=O)C(O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 RYMLPVGCISRSRQ-UHFFFAOYSA-N 0.000 abstract 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000006193 diazotization reaction Methods 0.000 abstract 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 abstract 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 abstract 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract 2
- 230000020477 pH reduction Effects 0.000 abstract 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 abstract 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 abstract 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 abstract 1
- SDGMUBWPXBSKCT-UHFFFAOYSA-N 1-chloro-4-methoxy-2-methylbenzene Chemical compound COC1=CC=C(Cl)C(C)=C1 SDGMUBWPXBSKCT-UHFFFAOYSA-N 0.000 abstract 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 1
- -1 2 - phenanthryl Chemical group 0.000 abstract 1
- BCGITRTXBFIXCC-UHFFFAOYSA-N 2-(2-bromophenyl)-2-oxoacetic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1Br BCGITRTXBFIXCC-UHFFFAOYSA-N 0.000 abstract 1
- LSETZDOAPDISOL-UHFFFAOYSA-N 2-(4-chloro-3-nitrophenyl)-2-oxoacetic acid Chemical compound OC(=O)C(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 LSETZDOAPDISOL-UHFFFAOYSA-N 0.000 abstract 1
- VRHXMFFTZGFEPY-UHFFFAOYSA-N 2-(4-formamidophenyl)-2-oxoacetic acid Chemical compound C(=O)NC1=CC=C(C=C1)C(C(=O)O)=O VRHXMFFTZGFEPY-UHFFFAOYSA-N 0.000 abstract 1
- QPDHXOFINFQQBM-UHFFFAOYSA-N 2-(5-chloro-2-methoxy-4-methylphenyl)-2-oxoacetic acid Chemical compound COC1=CC(C)=C(Cl)C=C1C(=O)C(O)=O QPDHXOFINFQQBM-UHFFFAOYSA-N 0.000 abstract 1
- MQMWPBBDMIYYMI-UHFFFAOYSA-N 2-aminophenylglyoxylic acid Chemical compound NC1=CC=CC=C1C(=O)C(O)=O MQMWPBBDMIYYMI-UHFFFAOYSA-N 0.000 abstract 1
- ISFFCSPHFNWPST-UHFFFAOYSA-N 2-methoxyimino-2-phenylacetic acid Chemical compound CON=C(C(O)=O)C1=CC=CC=C1 ISFFCSPHFNWPST-UHFFFAOYSA-N 0.000 abstract 1
- UIBNKYDBTMDABC-UHFFFAOYSA-N 2-methoxyimino-2-phenylacetyl chloride Chemical compound CON=C(C(Cl)=O)C1=CC=CC=C1 UIBNKYDBTMDABC-UHFFFAOYSA-N 0.000 abstract 1
- GUGQQGROXHPINL-UHFFFAOYSA-N 2-oxobutanoyl chloride Chemical compound CCC(=O)C(Cl)=O GUGQQGROXHPINL-UHFFFAOYSA-N 0.000 abstract 1
- YNNOFVDQHAHVFG-UHFFFAOYSA-N 3-phenylmethoxycyclobutane-1-carboxylic acid Chemical compound C1C(C(=O)O)CC1OCC1=CC=CC=C1 YNNOFVDQHAHVFG-UHFFFAOYSA-N 0.000 abstract 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract 1
- HETBKLHJEWXWBM-UHFFFAOYSA-N 4-chloro-3-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC(C=O)=CC=C1Cl HETBKLHJEWXWBM-UHFFFAOYSA-N 0.000 abstract 1
- RREPYIWLDJQENS-UHFFFAOYSA-N 4-nitrophenylglyoxylic acid Chemical compound OC(=O)C(=O)C1=CC=C([N+]([O-])=O)C=C1 RREPYIWLDJQENS-UHFFFAOYSA-N 0.000 abstract 1
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- SXJSICIFYMGOFE-UHFFFAOYSA-N IC=1C=C(C=CC1)C(C(=O)O)=O Chemical compound IC=1C=C(C=CC1)C(C(=O)O)=O SXJSICIFYMGOFE-UHFFFAOYSA-N 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 150000008065 acid anhydrides Chemical class 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 150000001540 azides Chemical class 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 239000012954 diazonium Substances 0.000 abstract 1
- 150000001989 diazonium salts Chemical class 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 239000011790 ferrous sulphate Substances 0.000 abstract 1
- 235000003891 ferrous sulphate Nutrition 0.000 abstract 1
- 235000019253 formic acid Nutrition 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 150000007857 hydrazones Chemical class 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical compound O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 1
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000802 nitrating effect Effects 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 150000002923 oximes Chemical class 0.000 abstract 1
- QOWOXBFFQOXPHM-UHFFFAOYSA-O oxo-[[1-[[4-(oxoazaniumylmethylidene)pyridin-1-yl]methyl]pyridin-4-ylidene]methyl]azanium;chloride Chemical compound [Cl-].C1=CC(=C[NH+]=O)C=CN1CN1C=CC(=C[NH+]=O)C=C1 QOWOXBFFQOXPHM-UHFFFAOYSA-O 0.000 abstract 1
- FAQJJMHZNSSFSM-UHFFFAOYSA-N phenylglyoxylic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1 FAQJJMHZNSSFSM-UHFFFAOYSA-N 0.000 abstract 1
- 125000005546 pivalic acid group Chemical group 0.000 abstract 1
- 239000004584 polyacrylic acid Substances 0.000 abstract 1
- 229920005990 polystyrene resin Polymers 0.000 abstract 1
- 235000011056 potassium acetate Nutrition 0.000 abstract 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 abstract 1
- 229960004919 procaine Drugs 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000007659 semicarbazones Chemical class 0.000 abstract 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 abstract 1
- 235000010262 sodium metabisulphite Nutrition 0.000 abstract 1
- 239000004296 sodium metabisulphite Substances 0.000 abstract 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/32—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1,208,014. Cephalosporins. GLAXO LABORATORIES Ltd. 12 March, 1968 [23 March, 1967], No. 13867/67. Headings C2A and C2C. [Also in Division A5] The invention comprises 7 - arylglyoxamido cephalosporanic acids of Formula I wherein Ar is an aromatic group (including a heterocyclic aromatic group e.g. pyridyl or thienyl) having an atomic weight of at least 78; a salt thereof and an α - carbonyl derivative thereof e.g. oxime, methoxime, hydrazone, semicarbazone, thiosemicarbazone and isonicotinoylhydrazone. Ar may be the group where R is NH 2 , substituted NH 2 , halo, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 alkoxycarbonyl, NO 2 or CN, n is 1 to 4, the groups R when n is greater than 1 being the same or different. Ar may be 1 - naphthyl or 2 - phenanthryl. Typical compounds are 7 - (p - dimethylaminophenylglyoxamido) cephalosporanic acid and 7 - (p - chlorophenylglyoxamido) cephalosporanic acid. The compounds are produced by acylating 7 - amino cephalosporanic acid with an aromatic glyoxylic acid Ar.CO.CO.COOH wherein Ar has the above meaning, or a reactive derivative thereof e.g. acid halide, reactive azide, anhydride or mixed acid anhydride with e.g. butyric, valeric, isovaleric, trifluoroacetic or pivalic acids. Salts are formed with the alkali and alkaline earth metals, organic bases e.g. procaine, acids (where Ar contains a basic group) and resins e.g. a polystyrene resin containing amino, quarternary amino or sulphonic acid groups or a resin containing carboxyl groups e.g. a polyacrylic acid resin. 5 - chloro - 2 - methoxy - 4 - methylphenylglyoxylic acid is prepared by reacting 2 - chloro - 5 - methoxy toluene with ethyl oxalyl chloride in the presence of aluminium chloride, followed by treatment with hydrochloric acid and hydrolysis with NaOH to remove the ester group. m - iodophenylglyoxylic acid is prepared by nitrating acetophenone to produce m - nitroacetophenone, subjecting m - nitroacetophenone to reduction, diazotization and treatment with potassium iodide to give m - iodoacetophenone, and treating m - iodoacetophenone with KMnO 4 and KOH, followed by acidification with hydrochloric acid. 4 - chloro - 3 - nitrophenyl glyoxylic acid is produced by reacting 4 - chloro - 3 - nitrobenzaldehyde with sodium metabisulphite and sodium cyanide to give 4 - chloro - 3 - nitromandelic acid, esterifying the 4 - chloro - 3 - nitromandelic acid with CH 3 OH and H 2 SO 4 and treating the resultant methyl ester with lead tetra acetate and then with NaOH followed by acidification. o - Bromophenylglyoxylic acid is produced by the diazotization of isatin and the addition of the resultant diazonium salt to a boiling mixture of CuSO 4 , copper, NaBr, H 2 SO 4 and water. p - Formamidophenylglyoxylic acid is prepared by reducing p - nitrophenylglyoxylic acid with ferrous sulphate in aqueous NH 4 OH to give p aminophenylglyoxylic acid, which is then treated with dry formic acid and acetic anhydride. α - methoximinophenylacetyl chloride is prepared by reacting phenylglyoxylic acid with methoxyammonium chloride previously treated with potassium acetate in methanol to form α - methoximinophenylacetic acid which is then treated with thionyl chloride. The cephalosporins are active antibiotics which may be administered orally (see Division A5). Specification 1,104,937 is referred to.
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB03867/67A GB1208014A (en) | 1967-03-23 | 1967-03-23 | Cephalosporins |
| CH411968A CH507984A (en) | 1967-03-23 | 1968-03-20 | Process for the preparation of 7-acylaminocephalosporanic acids |
| FR1556822D FR1556822A (en) | 1967-03-23 | 1968-03-20 | |
| FR144493A FR7572M (en) | 1967-03-23 | 1968-03-20 | |
| DK124068A DK124265B (en) | 1967-03-23 | 1968-03-22 | Analogous process for the preparation of cephalosporan derivatives or α-carbonyl derivatives or salts thereof or of the α-carbonyl derivatives. |
| NL6804139A NL156702B (en) | 1967-03-23 | 1968-03-22 | PROCESS FOR THE PREPARATION OF A CEPHALOSPORIN DERIVATIVE AND FORMED PREPARATION WITH ANTI-BACTERIAL ACTION CONTAINING SUCH CEPHALOSPORIN DERIVATIVE. |
| SE388168A SE364284B (en) | 1967-03-23 | 1968-03-22 | |
| DE19681770031 DE1770031A1 (en) | 1967-03-23 | 1968-03-22 | New derivatives of cephalosporin C and process for their preparation (1) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB03867/67A GB1208014A (en) | 1967-03-23 | 1967-03-23 | Cephalosporins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1208014A true GB1208014A (en) | 1970-10-07 |
Family
ID=10030837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB03867/67A Expired GB1208014A (en) | 1967-03-23 | 1967-03-23 | Cephalosporins |
Country Status (7)
| Country | Link |
|---|---|
| CH (1) | CH507984A (en) |
| DE (1) | DE1770031A1 (en) |
| DK (1) | DK124265B (en) |
| FR (2) | FR7572M (en) |
| GB (1) | GB1208014A (en) |
| NL (1) | NL156702B (en) |
| SE (1) | SE364284B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2223375A1 (en) * | 1971-05-14 | 1972-11-23 | Glaxo Lab Ltd | Antibiotics and their method of manufacture |
| JPS52108997A (en) * | 1976-03-09 | 1977-09-12 | Fujisawa Pharmaceut Co Ltd | 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and their salts and their preparation |
| JPS5248996B1 (en) * | 1971-01-29 | 1977-12-14 | Glaxo Lab Ltd | |
| US4201779A (en) | 1977-03-12 | 1980-05-06 | Hoechst Aktiengesellschaft | 7[(2-Amino-thiazol-4-yl)glyoxylamido]-cephem derivatives and processes for their preparation |
| US8993574B2 (en) | 2008-04-24 | 2015-03-31 | F2G Ltd | Pyrrole antifungal agents |
| US10201524B2 (en) | 2014-11-21 | 2019-02-12 | F2G Limited | Antifungal agents |
| US10973821B2 (en) | 2016-05-25 | 2021-04-13 | F2G Limited | Pharmaceutical formulation |
| US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE36041B1 (en) * | 1971-01-29 | 1976-08-04 | Glaxo Lab Ltd | Improvements in or relating to antibiotics |
| GB1389194A (en) * | 1971-01-29 | 1975-04-03 | Glaxo Lab Ltd | Antibiotics |
| DE2818263A1 (en) * | 1978-04-26 | 1979-11-08 | Bayer Ag | BETA LACTAMANTIBIOTICS |
| IT1211080B (en) * | 1981-07-21 | 1989-09-29 | Craf Sud | BIOLOGICALLY ACTIVE HYDRAZONOCEFEM. |
| GB8810393D0 (en) * | 1988-05-03 | 1988-06-08 | Glaxo Group Ltd | Chemical process |
-
1967
- 1967-03-23 GB GB03867/67A patent/GB1208014A/en not_active Expired
-
1968
- 1968-03-20 CH CH411968A patent/CH507984A/en not_active IP Right Cessation
- 1968-03-20 FR FR144493A patent/FR7572M/fr not_active Expired
- 1968-03-20 FR FR1556822D patent/FR1556822A/fr not_active Expired
- 1968-03-22 DK DK124068A patent/DK124265B/en unknown
- 1968-03-22 NL NL6804139A patent/NL156702B/en unknown
- 1968-03-22 DE DE19681770031 patent/DE1770031A1/en not_active Ceased
- 1968-03-22 SE SE388168A patent/SE364284B/xx unknown
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5248996B1 (en) * | 1971-01-29 | 1977-12-14 | Glaxo Lab Ltd | |
| DE2223375A1 (en) * | 1971-05-14 | 1972-11-23 | Glaxo Lab Ltd | Antibiotics and their method of manufacture |
| DE2265234A1 (en) * | 1971-05-14 | 1976-12-30 | Glaxo Lab Ltd | INTERMEDIATE PRODUCTS FOR ANTIBIOTICS AND PROCESS FOR THEIR MANUFACTURING |
| JPS531280B1 (en) * | 1971-05-14 | 1978-01-17 | ||
| JPS52108997A (en) * | 1976-03-09 | 1977-09-12 | Fujisawa Pharmaceut Co Ltd | 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and their salts and their preparation |
| US4201779A (en) | 1977-03-12 | 1980-05-06 | Hoechst Aktiengesellschaft | 7[(2-Amino-thiazol-4-yl)glyoxylamido]-cephem derivatives and processes for their preparation |
| US8993574B2 (en) | 2008-04-24 | 2015-03-31 | F2G Ltd | Pyrrole antifungal agents |
| US9452168B2 (en) | 2008-04-24 | 2016-09-27 | F2G Ltd | Pyrrole antifungal agents |
| US10201524B2 (en) | 2014-11-21 | 2019-02-12 | F2G Limited | Antifungal agents |
| US10596150B2 (en) | 2014-11-21 | 2020-03-24 | F2G Limited | Antifungal agents |
| US11065228B2 (en) | 2014-11-21 | 2021-07-20 | F2G Limited | Antifungal agents |
| US10973821B2 (en) | 2016-05-25 | 2021-04-13 | F2G Limited | Pharmaceutical formulation |
| US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
Also Published As
| Publication number | Publication date |
|---|---|
| DK124265B (en) | 1972-10-02 |
| NL6804139A (en) | 1968-09-24 |
| CH507984A (en) | 1971-05-31 |
| NL156702B (en) | 1978-05-16 |
| FR1556822A (en) | 1969-02-07 |
| FR7572M (en) | 1970-01-05 |
| DE1770031A1 (en) | 1971-09-16 |
| SE364284B (en) | 1974-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1208014A (en) | Cephalosporins | |
| GB1208015A (en) | Cephalosporins | |
| GB1283225A (en) | Derivatives of cyclopropane carboxylic acid and process for their preparation | |
| GB1456221A (en) | 3-hydroxy cephalosporins their ether derivatives and methods for their preparation | |
| ES371426A1 (en) | Synthesis of arylchlorocarbonyl ketenes | |
| GB1499026A (en) | Adriamycin esters | |
| GB1432649A (en) | ||
| GB1290879A (en) | ||
| GB1304647A (en) | ||
| GB980777A (en) | ª‡-amino-substituted penicillins | |
| GB1282493A (en) | A process for the preparation of dithioesters | |
| GB1306404A (en) | Indenopyridine derivatives | |
| IE34427B1 (en) | Substituted alkenoic acids and their preparation | |
| GB1042901A (en) | Production of 4-nitro-5-hydroxypyridazones-(6) | |
| GB1054209A (en) | ||
| GB986554A (en) | Penicillins | |
| GB1382996A (en) | Substituted biphenyls | |
| GB1382785A (en) | 1,4-ethano-2,3-dihydroquinoline derivatives | |
| JPS5549384A (en) | Novel antibacterial compound | |
| JPS5798258A (en) | Beta-lactamase inhibitor composition | |
| GB1365954A (en) | Process for acetylation | |
| GB1416987A (en) | Antibiotics | |
| GB934428A (en) | ||
| JPS5484590A (en) | 2-methyl-7-substituted-2 or 3-cephem-4-carboxylic acid, its salt, and their preparation | |
| GB1377248A (en) | Furan derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |